«Marbiopharm» is a modern enterprise with a well-developed infrastructure, which ships more than 70 different preparations from various pharmacological groups in the shape of pills, dragee, powders, capsules, tinctures, solutions, syrups on the market. More than 28% of it is included into the List of vital and essential medicines.
«Marbiopharm» remains a full technological cycle enterprise — from the chemical synthesis of the substances to the reception of finished pharmaceutical products based on it. Substances are produced for own use and are shipped to the large Russian companies for producing both nonsterile and sterile finished pharmaceuticals. Following substances are being produced nowadays: Ascorbic acid, lipoic acid, succinic acid, validol, methionine and others.
4 main workshops are involved into the structure of the manufacturing of the enterprise.
Manuracturing on «Marbiopharm is realized on the basis of a license for the production of medicines № 12491-ЛС-П from 03.07.2013, issued by the Ministery of Indusrty and Trade of the Russian Federation. The license is perpetual .
License № ЛО-12-03-000047 from 29.07.2013 is for the implementation of traffic of the narcotic drugs, psychotropic substances and their precursors.
The products of the factory are characterized by top quality, is selled all around Russia, in the near abroad and in Baltic countries. Enterprise cooperates with a large pharmacy chains, doing work on releasing the products through the STM of these chains.
The calling card of the factory are the preparations in the shape of dosed sachet powder under its own trade sign ГриппоФлю® — for curing the cold and flu symptoms.
«Marbiopharm» releases wide range of syrups based on vegetable raw materials — wild rose, hawthorn, red mountain ash, chokeberry Aronia, plantain, Rhodiola rosea. The unique technology allows to produce the concentrated extracts of the components from plant material without using preservatives, colorants, flavorings.
The enterprise regularly provides training for staff at all levels, because qualified personell is the key to stability.
«Marbiopharm» modernizing and expanding its production technology base according to the Development program of the «Marbiopharm».